Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.6756 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.88511 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.88734 | 39 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.73233 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.98704 | 44 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.08923 | 43 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.92022 | 38 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.87 | 39 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.84908 | 38 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.36827 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.88091 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.81043 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.8933 | 39 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.88473 | 39 |